Why Modern Enterprises Choose Drupal
More Than a CMS. A Composable Digital Experience Platform.
When your digital needs outgrow basic templates and rigid systems, you need a platform engineered for flexibility, scalability, and integration. Drupal is the open-source powerhouse chosen by global enterprises to build digital experiences that are secure, adaptable, and built to last.
Recent releases
|
Engagement Lessons Pharma CMOs Should Steal from Netflix
Why Netflix Should Be in Your Next Marketing Meeting. If you think that's a weird question, we have an answer! If you’re a pharma CMO in India, your biggest challenge isn’t reach. It’s relevance…
|
Pharma Data Strategy Boosting Marketing and Prescription ROI
Pharma data strategy empowers marketers to unify HCP engagement, integrate analytics, automate compliance, and drive consistent prescription growth and ROI.
|
How the Best Healthcare Digital Marketing Agency Scales
Pharma marketing in India has no shortage of pilots. Every quarter, a new “digital-first” idea is tested a chatbot here, a WhatsApp drip there, maybe a webinar series that looked exciting…
|
Pharma Sales Transformation Empowering Field Force RO
Pharma sales transformation empowers marketing leaders to align field and digital operations, automate compliance, and deliver measurable prescription growth ROI.
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
